Table 2.

Medication Profile of Schizophrenia Patients

Drugs	National Insurance Patients				Uninsured Patients				Total Patients
	2016	2017	2018	Total	2016	2017	2018	Total	2016	2017	2018	Total
	n	n	n	n	n	n	n	n	n (%)	n (%)	n (%)	n (100%)
Typical Antipsychotics
Chlorpromazine	7	7	0	14	1	0	0	1	8 (15.1)	7 (10.1)	0 (0)	15 (10.0)
Fluphenazine	0	1	0	1	1	0	0	1	1 (1.9)	1 (1.4)	0 (0)	2 (1.3)
Haloperidol	7	12	3	22	0	2	0	2	7 (13.2)	14 (20.3)	3 (10.7)	24 (16.0)
Trifluoperazine	1	1	1	3	2	0	0	2	3 (5.7)	1 (1.4)	1 (3.6)	5 (3.3)
	15	21	4	40	4	2	0	6	19 (35.8)	23 (33.3)	4 (14.3)	46 (30.7)
Atypical Antipsychotics
Aripiprazole	0	0	1	1	0	0	0	0	0 (0)	0 (0)	1 (3.6)	1 (0.7)
Clozapine	2	6	1	9	2	0	0	2	4 (7.5)	6 (8.7)	1 (3.6)	11 (7.3)
Olanzapine	0	2	0	2	1	0	0	1	1 (1.9)	2 (2.9)	0 (0)	3 (2.0)
Quetiapine	0	2	1	3	0	0	0	0	0 (0)	2 (2.9)	1 (3.6)	3 (2.0)
Risperidone	3	8	9	20	4	6	4	14	7 (13.2)	14 (20.3)	13 (46.4)	34 (22.7)
	5	18	12	35	7	6	4	17	12 (22.6)	24 (34.8)	16 (57.1)	52 (34.7)
Anticholinergics
Trihexyphenidyl	12	13	2	27	9	3	0	12	21 (39.6)	16 (23.3)	2 (7.1)	39 (26.0)
Benzodiazepines
Lorazepam	0	3	3	6	1	0	2	3	1 (1.9)	3 (4.3)	5 (17.9)	9 (6.0)
Clobazam	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
Alprazolam	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
Diazepam	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
	0	3	3	6	1	0	2	3	1 (1.9)	3 (4.3)	5 (17.9)	9 (6.0)
Antidepressants
SSRIs
Fluoxetine	0	1	1	2	0	2	0	2	0 (0)	3 (4.3)	1 (3.6)	4 (2.7)
Sertraline	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
TCAs
Amitriptyline	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
TeCAs
Maprotiline	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
	0	1	1	2	0	2	0	2	0 (0)	3 (4.3)	1 (3.6)	4 (2.7)
Mood Stabilizers
Carbamazepine	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
Sodium divalproex	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
	0	0	0	0	0	0	0	0	0 (0)	0 (0)	0 (0)	0 (0)
Total	32	56	22	110	21	13	6	40	53 (100)	69 (100)	28 (100)	150 (100)

Abbreviations: SSRIs, sel SSRIs, Selective serotonin reuptake inhibitors; TCAs, tricyclic antidepressants; TeCAs, tetracyclic antidepressants; n, number of patients.